REGENXBIO Inc — Dividend History & Yield (NASDAQ:RGNX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Nouvelles

Stifel commente les actions uniQure après les remarques du commissaire de la FDA

Stifel comments on uniQure shares after FDA commissioner remarks

Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug

Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com

REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)

Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection

Le rejet de la FDA assombrit le chemin du traitement des maladies rares de REGENXBIO | Benzinga France

Intel, Wells Fargo among market cap stock movers on Tuesday

Netflix and Oracle among market cap stock movers on Tuesday

Goldman Sachs abaisse l’objectif de cours de Regenxbio suite au revers de RGX-121

Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback